- Report
- March 2025
- 83 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- March 2025
- 179 Pages
Global
From €5182EUR$5,450USD£4,357GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 192 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 194 Pages
Global
From €5182EUR$5,450USD£4,357GBP
- Report
- March 2025
- 187 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 292 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 293 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- March 2025
- 411 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- February 2025
- 178 Pages
Global
From €5182EUR$5,450USD£4,357GBP
- Report
- February 2025
- 216 Pages
Global
From €5182EUR$5,450USD£4,357GBP
- Report
- February 2025
- 135 Pages
Global
From €2368EUR$2,490USD£1,991GBP
- Report
- March 2025
- 175 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- March 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- March 2025
- 250 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more